Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Fundamental & Clinical Pharmacology
|
May 25, 2005
Assessing immunotoxicity of pharmaceuticals: the need for enhanced testing
Danuta J Herzyk
Current Opinion in Molecular Therapeutics
|
May 30, 2003
The immunogenicity of therapeutic cytokines
Danuta J Herzyk
Journal of Immunotoxicology
|
October 30, 2008
Immunotoxicity evaluation by immune function tests: focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA]
Danuta J Herzyk, Michael Holsapple
The AAPS Journal
|
February 9, 2018
Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies
Danuta J Herzyk, Helen G Haggerty
Toxicology Letters
|
April 20, 2004
Adequate immunotoxicity testing in drug development
Danuta J Herzyk, Elizabeth R Gore
Methods in Molecular Biology (Clifton, N.J.)
|
December 8, 2009
The T-dependent antibody response to keyhole limpet hemocyanin in rodents
Lisa M Plitnick, Danuta J Herzyk
Toxicologic Pathology
|
December 25, 2003
Preclinical safety of recombinant human interleukin-18
Danuta J Herzyk, Peter J Bugelski, Timothy K Hart, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
April 11, 2016
An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors
Frederique M Poulet, Jayanthi J Wolf, Danuta J Herzyk, et al.
Clinical Immunology (Orlando, Fla.)
|
November 5, 2003
Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species
Jeanne M Soos, Rodd M Polsky, Sean P Keegan, et al.
Toxicology
|
March 9, 2004
Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation
Elizabeth R Gore, Jill Gower, Edit Kurali, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Fundamental & Clinical Pharmacology
|
May 25, 2005
Assessing immunotoxicity of pharmaceuticals: the need for enhanced testing
Danuta J Herzyk
Current Opinion in Molecular Therapeutics
|
May 30, 2003
The immunogenicity of therapeutic cytokines
Danuta J Herzyk
Journal of Immunotoxicology
|
October 30, 2008
Immunotoxicity evaluation by immune function tests: focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA]
Danuta J Herzyk, Michael Holsapple
The AAPS Journal
|
February 9, 2018
Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies
Danuta J Herzyk, Helen G Haggerty
Toxicology Letters
|
April 20, 2004
Adequate immunotoxicity testing in drug development
Danuta J Herzyk, Elizabeth R Gore
Methods in Molecular Biology (Clifton, N.J.)
|
December 8, 2009
The T-dependent antibody response to keyhole limpet hemocyanin in rodents
Lisa M Plitnick, Danuta J Herzyk
Toxicologic Pathology
|
December 25, 2003
Preclinical safety of recombinant human interleukin-18
Danuta J Herzyk, Peter J Bugelski, Timothy K Hart, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
April 11, 2016
An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors
Frederique M Poulet, Jayanthi J Wolf, Danuta J Herzyk, et al.
Clinical Immunology (Orlando, Fla.)
|
November 5, 2003
Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species
Jeanne M Soos, Rodd M Polsky, Sean P Keegan, et al.
Toxicology
|
March 9, 2004
Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation
Elizabeth R Gore, Jill Gower, Edit Kurali, et al.
Page
of 2